Australia
Brazil
Canada
Germany
India
Ireland
Japan
Mexico
New Zealand
Philippines
South Africa
United Kingdom
Medical Mentor
From Medscape
Science
Medscape InDiscussion: Schizophrenia
by Medscape
Today: #175 in Science, Japan on our combined chart.
Today: #60 in Science, South Africa on our combined chart.
Chart positions today · United States
Not on the United States charts we track today.
Not on the United Kingdom charts we track today.
Not on the Canada charts we track today.
Not on the Australia charts we track today.
Not on the Germany charts we track today.
Not on the Brazil charts we track today.
Not on the Mexico charts we track today.
Not on the New Zealand charts we track today.
Not on the Ireland charts we track today.
Not on the India charts we track today.
Not on the Philippines charts we track today.
If you like Medscape InDiscussion: Schizophrenia, try…
This Week in Cardiology
From Medscape
Inside Schizophrenia
Similar topics: schizophrenia and treatment
This Is Your Brain On Drugs Psychiatry Podcast
Similar topics: schizophrenia and antipsychotics
Schizophrenia: Three Moms in the Trenches
Similar topics: schizophrenia and families
Psychopharmacology and Psychiatry Updates
Similar topics: schizophrenia and antipsychotics
Ranking history · United States
No ranking history for this show in United States over the last 14 days.
Latest episodes
-
Is MDMA a Potential Treatment for Negative Symptoms of Schizophrenia? Exploring Stigma and Strategies to Alleviate Symptoms
July 20, 2023 · 22 minDrs John M. Kane and Mitchell Arnovitz discuss assessment of patients for negative symptoms of schizophrenia and the potential of MDMA in alleviating these symptoms in supervised treatment settings. Relevant disclosures can be found with…
-
First-Episode Schizophrenia: The Importance of Engaging and Educating Patients and Their Families in Treatment
June 21, 2023 · 22 minDrs John M. Kane and Delbert G. Robinson discuss psychoeducation, treatment options, and possible side effects of medication for patients experiencing their first episode of schizophrenia. Relevant disclosures can be found with the…
-
Common and Commonly Unrecognized: Clinical High-risk Syndrome, Psychosis, and Schizophrenia
May 23, 2023 · 19 minDrs John M. Kane and Scott W. Woods discuss clinical high-risk syndrome and schizophrenia, including assessment methods, interventions, and risk indicators for future psychosis. Relevant disclosures can be found with the episode show…
-
Psychiatric Comorbidity in Schizophrenia: Assessing Patients and the Impact on Treatment Decisions and Outcomes
April 19, 2023 · 25 minDrs John M. Kane and Christoph U. Correll discuss the importance of ongoing assessment of psychiatric comorbidities in patients with schizophrenia and its impact on outcomes and treatment decisions. Relevant disclosures can be found with…
-
Long-Acting Injectables and Schizophrenia: Mitigating the Risk for Relapse and Rehospitalization
March 22, 2023 · 24 minDrs John M. Kane and Jose Rubio-Lorente discuss the value of long-acting injectable formulations in reducing the risk for relapse and rehospitalization for patients diagnosed with schizophrenia. Relevant disclosures can be found with the…
Show 7 more episodesShow fewer episodes
-
Treatment-Resistant Schizophrenia: Detection, Management, and the Importance of Early Initiation of Treatment
March 22, 2023 · 26 minDrs John M. Kane and Jonathan Meyer discuss treatment-resistant schizophrenia, how common it is, how to detect and manage it, and how delays in the initiation of treatment negatively affect patients. Relevant disclosures can be found with…
-
Relapse in Schizophrenia: Why It Occurs, How Often It Occurs, and What We Can Do About It
December 7, 2022 · 24 minDrs John Kane and Jose Rubio-Lorente discuss relapse in schizophrenia — why it occurs, how often it occurs, and what we can do about it. Relevant disclosures can be found with the episode show notes on Medscape (https:/…
-
Neuroimaging in Schizophrenia: What Have We Learned?
November 9, 2022 · 22 minDrs John Kane and Anil Malhotra discuss neuroimaging and connectivity between various regions of the brain in patients with schizophrenia and how it impacts the pathophysiology and treatment response. Relevant disclosures can be found…
-
How Can We Assess Cognitive Functioning in Patients With Schizophrenia? And What Can We Do About It?
October 5, 2022 · 25 minDrs John Kane and Philip D. Harvey discuss how physicians can assess cognitive functioning in patients with schizophrenia and how to utilize rehabilitation and technology to address it. Relevant disclosures can be found with the episode…
-
What New Antipsychotic Drugs Are Available for Schizophrenia? What Drugs Are Under Development? And What Do They Potentially Offer?
September 13, 2022 · 23 minDrs John Kane and Jonathan M. Meyer discuss what new antipsychotic drugs are available for schizophrenia. What drugs are under development? And what do they potentially offer? Relevant disclosures can be found with the episode show notes…
-
Antipsychotics in Schizophrenia: Effectiveness and Optimal Dosing
August 2, 2022 · 26 minDrs John Kane and Stefan Leucht discuss the effectiveness and optimal dosing of antipsychotic medications in the treatment of schizophrenia. Relevant disclosures can be found with the episode show notes on Medscape (htt…
-
What Are the Major Metabolic and Neurologic Risks Associated With Antipsychotic Medications?
August 2, 2022 · 25 minDrs John Kane and Christoph U. Correll discuss the major metabolic and neurologic risks associated with antipsychotic medications for patients diagnosed with schizophrenia. Relevant disclosures can be found with the episode show notes on…
About the show
Listen to Medscape InDiscussion: Schizophrenia, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/984480). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.